PHARMAS CRUSHED BY THE NOVO SPELL
02/01/25 -"Pharmas closed the year with a dreadful performance, itself the reflection of dashed excessive hopes for GLP-1 developments. The unwarranted Novo Nordisk collapse on 19-12 on a marginal miss in its ..."
Pages
60
Language
English
Published on
02/01/25
You may also be interested by these reports :
11/09/25
Equinor Chairman J.E.Reinhardsen said yesterday that Equinor has an “open mind” regarding the structure of its partnership with Ørsted A/S, including ...
05/09/25
Our 2025 EPS estimates are downgraded following Ørsted’s announcement of an EBITDA shortfall of DKK 1.5bn due to weaker than normal winds this July ...
05/09/25
After a DKK 60bn rights issue and the suspension of Revolution Wind, the Danish offshore wind developer has issued a 2025 profit warning. The ...
04/09/25
Iberdrola (Reduce; Spain) may be the best call for investing in infrastructure related to the energy transition, offering both a robust geographical ...